title: In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II.
abstract: Chemokines play a central role in immune and inflammatory responses. It has been observed recently that certain viruses have evolved molecular piracy and mimicry mechanisms by encoding and synthesizing proteins that interfere with the normal host defense response. One such viral protein, vMIP-II, encoded by human herpesvirus 8, has been identified with in vitro antagonistic activities against CC and CXC chemokine receptors. We report here that vMIP-II has additional antagonistic activity against CX3CR1, the receptor for fractalkine. To investigate the potential therapeutic effect of this broad-spectrum chemokine antagonist, we studied the antiinflammatory activity of vMIP-II in a rat model of experimental glomerulonephritis induced by an antiglomerular basement membrane antibody. vMIP-II potently inhibited monocyte chemoattractant protein 1-, macrophage inflammatory protein 1beta-, RANTES (regulated on activation, normal T cell expressed and secreted)-, and fractalkine-induced chemotaxis of activated leukocytes isolated from nephritic glomeruli, significantly reduced leukocyte infiltration to the glomeruli, and markedly attenuated proteinuria. These results suggest that molecules encoded by some viruses may serve as useful templates for the development of antiinflammatory compounds.
authors.affiliation: Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.
authors.forename: S
authors.initials: S
authors.lastname: Chen
authors.forename: K B
authors.initials: KB
authors.lastname: Bacon
authors.forename: L
authors.initials: L
authors.lastname: Li
authors.forename: G E
authors.initials: GE
authors.lastname: Garcia
authors.forename: Y
authors.initials: Y
authors.lastname: Xia
authors.forename: D
authors.initials: D
authors.lastname: Lo
authors.forename: D A
authors.initials: DA
authors.lastname: Thompson
authors.forename: M A
authors.initials: MA
authors.lastname: Siani
authors.forename: T
authors.initials: T
authors.lastname: Yamamoto
authors.forename: J K
authors.initials: JK
authors.lastname: Harrison
authors.forename: L
authors.initials: L
authors.lastname: Feng
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000494:pharmacology; D001485:Basement Membrane / Q000276:immunology; D001667:Binding, Competitive; D000073883:CX3C Chemokine Receptor 1; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology*; D018925:Chemokines / Q000494:pharmacology* / Q000627:therapeutic use; D002633:Chemotaxis / Q000187:drug effects; D004195:Disease Models, Animal; D005921:Glomerulonephritis / Q000503:physiopathology*; D019288:Herpesvirus 8, Human / Q000737:chemistry; D007150:Immunohistochemistry; D007249:Inflammation / Q000503:physiopathology; D007678:Kidney Glomerulus / Q000166:cytology / Q000276:immunology; D007962:Leukocytes / Q000378:metabolism*; D011507:Proteinuria / Q000503:physiopathology; D051381:Rats; D011919:Rats, Inbred Strains; D018121:Receptors, Cytokine / Q000037:antagonists & inhibitors*; D015728:Receptors, HIV / Q000037:antagonists & inhibitors*; D014764:Viral Proteins / Q000494:pharmacology
chemical_list: D000906:Antibodies; D000073883:CX3C Chemokine Receptor 1; D018925:Chemokines; D018121:Receptors, Cytokine; D015728:Receptors, HIV; D014764:Viral Proteins; C108059:vMIP-II